Get started
Author

Cecilia Ysabel Arana Yi

Final report of phase I/II study of PR104, a hypoxia-activated pro-drug, in relapsed/refractory acute leukemia.
2013 · Cecilia Ysabel Arana Yi, Gautam Borthakur, et al. · Journal of Clinical Oncology · 4
Predictors of survival outcomes in patients with MECOM EVI1 rearrangement aberrations in AML or MDS.
2023 · Yael Kusne, Alyssa McGary, et al. · Journal of Clinical Oncology · 3
PDF
A phase 1 study of CD38-bispecific antibody (XmAb18968) for patients with CD38 expressing relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
2022 · Guru Subramanian Guru Murthy, Tyce Kearl, et al. · Journal of Clinical Oncology · 3
Prognostic impact of trisomy 8 cytogenetic abnormality in acute myelogenous leukemia: Analysis of a large cohort (N=2187) of newly diagnosed patients.
2013 · Gautam Borthakur, Cecilia Ysabel Arana Yi, et al. · Journal of Clinical Oncology · 3
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): Prognostic factors and outcomes in 68 Mayo Clinic patients.
2025 · Erica Andres, Clifford Michael Csizmar, et al. · Journal of Clinical Oncology · 1
PDF
Determinants of survival in 356 patients failing frontline HMA-Ven for newly-diagnosed AML.
2026 · Mahnoor Fatima, Sudhesh Kumar, et al. · Journal of Clinical Oncology
HMA plus venetoclax for 7- vs 14- vs 21- vs 28-day cycles in newly-diagnosed acute myeloid leukemia: ELN- and Mayo Genetic Risk–stratified analysis in 540 patients.
2026 · Sudhesh Kumar, Momna Warraich, et al. · Journal of Clinical Oncology
Validation of the International Consensus Classification (ICC) for systemic mastocytosis and the Mayo Alliance Prognostic Score (MAPS) in 910 consecutive patients.
2025 · Fnu Aperna, Animesh Dev Pardanani, et al. · Journal of Clinical Oncology
Characteristics and prognosis of DDX41- and GATA2-mutated myeloid neoplasms.
2022 · Ahmad Nanaa, Hassan B. Alkhateeb, et al. · Journal of Clinical Oncology
Phase II trial of luspatercept with or without hydroxyurea for the treatment of patients with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis or unclassifiable with ring sideroblasts.
2022 · Abhishek Avinash Mangaonkar, Cecilia Ysabel Arana Yi, et al. · Journal of Clinical Oncology
Characteristics and prognosis of mutated STAG2 myeloid neoplasms.
2022 · Bahga Katamesh, Ahmad Nanaa, et al. · Journal of Clinical Oncology
Clinical implications of discrepancy in the diagnosis of primary myelofibrosis between referral and tertiary center.
2013 · Ghayathri Jeyakumar, Cecilia Ysabel Arana Yi, et al. · Journal of Clinical Oncology
Works count: 12
Citation count: 14
H-index: 3
I10-index:
Year
Topic
Type